Related Experiment Video
Updated: Sep 10, 2025

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
Published on: July 21, 2021
Design of multi-target peptide modulators for protein chaperone networks
Luca Torielli1, Matteo Castelli1, Francesca Milani1
1Department of Chemistry, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.
Researchers designed a novel peptide, Cdk4-2, that simultaneously targets key cancer-associated proteins heat shock protein 70 (Hsp70) and heat shock protein 90 (Hsp90). This peptide shows promise for cancer therapy by inhibiting tumor growth and inducing cell death.
Area of Science:
- Molecular Biology
- Drug Discovery
- Cancer Research
Background:
- Heat shock proteins (Hsp70 and Hsp90) are crucial for cancer oncoprotein folding.
- Dual inhibition of these chaperones offers synergistic therapeutic potential but is difficult to achieve.
- Targeting chaperone networks presents a novel strategy for cancer treatment.
Purpose of the Study:
- To computationally design peptides that mimic unfolding regions of CDK4, a client protein of Hsp70 and Hsp90.
- To develop a multi-target modulator for inhibiting chaperone networks involved in cancer.
- To evaluate the therapeutic potential of designed peptides in renal carcinoma cells.
Main Methods:
- Computational peptide design based on predicted protein unfolding regions.
- In silico screening and structure-function studies for peptide-target interactions.
- In vitro assays to assess peptide membrane permeability, enzyme inhibition, and apoptosis induction.
Main Results:
- Peptide Cdk4-2 was designed to bind Hsp70, Hsp90, and Cdc37 simultaneously.
- Cdk4-2 demonstrated membrane permeability and inhibited CDK4-mediated retinoblastoma phosphorylation.
- The peptide induced apoptosis in renal carcinoma cells, showing therapeutic efficacy.
- Structure-function analysis identified key binding interactions and a minimal pharmacophore for Hsp70.
Conclusions:
- Rational design of multi-target modulators for chaperone networks is feasible.
- Cdk4-2 is a promising therapeutic lead for cancer treatment, targeting multiple proteins.
- The strategy is transferable to other multiprotein targets and networks beyond chaperones.
Related Concept Videos
Molecular Chaperones and Protein Folding
The...
Bacterial Protein Maturation
Protein-protein Interfaces
Mitochondrial Precursor Proteins
Most of the mitochondrial...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Cooperative Allosteric Transitions

